AstraZeneca To Pay $425M To Settle Claims Heartburn Drugs Damaged Kidneys
AstraZeneca on Oct. 3 announced that it has agreed to pay $425 million to settle claims that its Nexium and Prilosec products, used to treat heartburn, caused chronic kidney disease....To view the full article, register now.
Already a subscriber? Click here to view full article